相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Comparison of Machine Learning-based Approaches to Predict the Conversion to Alzheimer?s Disease from Mild Cognitive Impairment
Raffaella Franciotti et al.
NEUROSCIENCE (2023)
Ocular Biomarkers for Alzheimer Disease Dementia An Umbrella Review of Systematic Reviews and Meta-analyses
Eliana Costanzo et al.
JAMA OPHTHALMOLOGY (2023)
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4
Michael W. Weiner et al.
ALZHEIMERS & DEMENTIA (2023)
Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?
Chunyuan Yin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications
Fernando Gonzalez-Ortiz et al.
MOLECULAR NEURODEGENERATION (2023)
Blood biomarkers for Alzheimer's disease in clinical practice and trials
Oskar Hansson et al.
NATURE AGING (2023)
Blood-Based Alzheimer's Biomarkers
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Navigating the pitfalls of applying machine learning in genomics
Sean Whalen et al.
NATURE REVIEWS GENETICS (2022)
Quantification of amyloid PET for future clinical use: a state-of-the-art review
Hugh G. Pemberton et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
Maciej Dulewicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Deep learning methods to predict amyotrophic lateral sclerosis disease progression
Corrado Pancotti et al.
SCIENTIFIC REPORTS (2022)
Deep Neural Networks and Tabular Data: A Survey
Vadim Borisov et al.
IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS (2022)
Multi-task deep autoencoder to predict Alzheimer's disease progression using temporal DNA methylation data in peripheral blood
Li Chen et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Charlotte E. Teunissen et al.
LANCET NEUROLOGY (2022)
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative
Thomas K. Karikari et al.
MOLECULAR PSYCHIATRY (2021)
Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective
Ji-Peng Olivia Li et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2021)
Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease
Chun-Hung Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment
Amir H. Meghdadi et al.
PLOS ONE (2021)
A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease
Shaker El-Sappagh et al.
SCIENTIFIC REPORTS (2021)
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
Shorena Janelidze et al.
JAMA NEUROLOGY (2021)
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services-part 2 of 6
Janice M. Ranson et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Biomarker discovery studies for patient stratification using machine learning analysis of omics data: a scoping review
Enrico Glaab et al.
BMJ OPEN (2021)
Four distinct trajectories of tau deposition identified in Alzheimer's disease
Jacob W. Vogel et al.
NATURE MEDICINE (2021)
Aging brain mechanics: Progress and promise of magnetic resonance elastography
Lucy Hiscox et al.
NEUROIMAGE (2021)
Personalized profiles for disease risk must capture all facets of health
Mark McCarthy et al.
NATURE (2021)
Biomarkers for neurodegenerative diseases
Oskar Hansson
NATURE MEDICINE (2021)
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures
Sebastian Palmqvist et al.
NATURE MEDICINE (2021)
Molecular subtyping of Alzheimer's disease with consensus non-negative matrix factorization
Chunlei Zheng et al.
PLOS ONE (2021)
Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores
Ganna Leonenko et al.
NATURE COMMUNICATIONS (2021)
A multicentre validation study of the diagnostic value of plasma neurofilament light
Nicholas J. Ashton et al.
Nature Communications (2021)
Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence
Gary S. Collins et al.
BMJ OPEN (2021)
Synaptic density in carriers of C9orf72 mutations: a [11C] UCB-J PET study
Maura Malpetti et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial
Jennifer Ngolab et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease
Jennifer Tremblay-Mercier et al.
NEUROIMAGE-CLINICAL (2021)
Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
Alana C. Costa et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
Carina Wattmo et al.
BMC NEUROLOGY (2020)
A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap
AmanPreet Badhwar et al.
BRAIN (2020)
Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia; a population-based cohort study
Frank de Wolfa et al.
BRAIN (2020)
How to do things with (thousands of) words: Computational approaches to discourse analysis in Alzheimer's disease
Natasha Clarke et al.
CORTEX (2020)
Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data
Sascha Gill et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Relationship between dementia and gut microbiome-associated metabolites: a cross-sectional study in Japan
Naoki Saji et al.
SCIENTIFIC REPORTS (2020)
The reliability of a deep learning model in clinical out-of-distribution MRI data: A multicohort study
Gustav Martensson et al.
MEDICAL IMAGE ANALYSIS (2020)
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Nicholas J. Ashton et al.
NATURE REVIEWS NEUROLOGY (2020)
A comprehensive systematic review of CSF proteins and peptides that define Alzheimer's disease
Cristina M. Pedrero-Prieto et al.
CLINICAL PROTEOMICS (2020)
Neurophysiological Hallmarks of Neurodegenerative Cognitive Decline: The Study of Brain Connectivity as a Biomarker of Early Dementia
Paolo Maria Rossini et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Jakob M. Bader et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Applications of machine learning to diagnosis and treatment of neurodegenerative diseases
Monika A. Myszczynska et al.
NATURE REVIEWS NEUROLOGY (2020)
Artificial intelligence and neuropsychological measures: The case of Alzheimer's disease
Petronilla Battista et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database
Juan Felipe Beltran et al.
PLOS ONE (2020)
Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach
Negar Sadat Soleimani Zakeri et al.
SCIENTIFIC REPORTS (2020)
Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through RNA sequencing analysis
Daichi Shigemizu et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features
Alfonso Di Costanzo et al.
SCIENTIFIC REPORTS (2020)
Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis
Aiysha Chaudhry et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Inclusion of ethnoracial populations and diversity remains a key challenge in Alzheimer's disease biofluid-based biomarker studies
Ganesh M. Babulal
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction
Annette Spooner et al.
SCIENTIFIC REPORTS (2020)
A semi-supervised approach for rapidly creating clinical biomarker phenotypes in the UK Biobank using different primary care EHR and clinical terminology systems
Spiros Denaxas et al.
JAMIA OPEN (2020)
The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database
Stan Benjamens et al.
NPJ DIGITAL MEDICINE (2020)
Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
Joseph Giorgio et al.
NEUROIMAGE-CLINICAL (2020)
Artificial intelligence (AI) and big data in cancer and precision oncology
Zodwa Dlamini et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Not-so-supervised: A survey of semi-supervised, multi-instance, and transfer learning in medical image analysis
Veronika Cheplygina et al.
MEDICAL IMAGE ANALYSIS (2019)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Predicting Alzheimer's disease progression using multi-modal deep learning approach
Garam Lee et al.
SCIENTIFIC REPORTS (2019)
Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease
Ivan Koychev et al.
BMJ OPEN (2019)
A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease
Chia-Ni Lin et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Neuroimaging Biomarkers for Alzheimer's Disease
Freddie Marquez et al.
MOLECULAR NEURODEGENERATION (2019)
Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine
J. A. Duce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Research Techniques Made Simple: Feature Selection for Biomarker Discovery
Rodrigo Torres et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Biomarker-guided clustering of Alzheimer's disease clinical syndromes
Nicola Toschi et al.
NEUROBIOLOGY OF AGING (2019)
Prediction and Classification of Alzheimer's Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers
Yubraj Gupta et al.
FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2019)
Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer's Disease: The Paradigmatic Example of CSF
Marco Canevelli et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Artificial intelligence and deep learning in ophthalmology
Daniel Shu Wei Ting et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Oliver Preische et al.
NATURE MEDICINE (2019)
Digital biomarkers for Alzheimer's disease: the mobile/wearable devices opportunity
Lampros C. Kourtis et al.
NPJ DIGITAL MEDICINE (2019)
Improving PET Imaging Acquisition and Analysis With Machine Learning: A Narrative Review With Focus on Alzheimer's Disease and Oncology
Ian R. Duffy et al.
MOLECULAR IMAGING (2019)
Salivary Biomarkers for Alzheimer's Disease and Related Disorders
Nicholas J. Ashton et al.
NEUROLOGY AND THERAPY (2019)
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Daniel Stamate et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
The role of biomarkers and imaging in the clinical diagnosis of dementia
Antony J. Bayer
AGE AND AGEING (2018)
Biomarker definitions and their applications
Robert M. Califf
EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods
Fang Yao et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction
Seong Ho Park et al.
RADIOLOGY (2018)
Neurocognitive disorders in ICD-11: the debate and its outcome
Wolfgang Gaebel et al.
WORLD PSYCHIATRY (2018)
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Vijay R. Varma et al.
PLOS MEDICINE (2018)
Combining viscoelasticity, diffusivity and volume of the hippocampus for the diagnosis of Alzheimer's disease based on magnetic resonance imaging
Lea M. Gerischer et al.
NEUROIMAGE-CLINICAL (2018)
An Artificial Neural Network Integrated Pipeline for Biomarker Discovery Using Alzheimer's Disease as a Case Study
Dimitrios Zafeiris et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Clinically applicable deep learning for diagnosis and referral in retinal disease
Jeffrey De Fauw et al.
NATURE MEDICINE (2018)
Phenotypic Heterogeneity in Dementia: A Challenge for Epidemiology and Biomarker Studies
Joanne Ryan et al.
FRONTIERS IN PUBLIC HEALTH (2018)
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
Niklas Mattsson et al.
NEUROBIOLOGY OF AGING (2017)
Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment Results From the Gait and Brain Study
Manuel M. Montero-Odasso et al.
JAMA NEUROLOGY (2017)
Selection bias in the reported performances of AD classification pipelines
Alex F. Mendelson et al.
NEUROIMAGE-CLINICAL (2017)
Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study
Vincent Chouraki et al.
ALZHEIMERS & DEMENTIA (2017)
Imaging plus X: multimodal models of neurodegenerative disease
Neil P. Oxtoby et al.
CURRENT OPINION IN NEUROLOGY (2017)
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
Kaj Blennow
NEUROLOGY AND THERAPY (2017)
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation
Julia Kuhlmann et al.
CLINICA CHIMICA ACTA (2017)
A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers
Marije Oosterhoff et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2016)
Imaging and machine learning techniques for diagnosis of Alzheimer's disease
Golrokh Mirzaei et al.
REVIEWS IN THE NEUROSCIENCES (2016)
Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?
Bryce A. Mander et al.
TRENDS IN NEUROSCIENCES (2016)
Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study
A. Rongve et al.
BMJ OPEN (2016)
Changes in the Chemical Barrier Composition of Tears in Alzheimer's Disease Reveal Potential Tear Diagnostic Biomarkers
Gergo Kallo et al.
PLOS ONE (2016)
Common polygenic variation enhances risk prediction for Alzheimer's disease
Valentina Escott-Price et al.
BRAIN (2015)
Potential Application of Machine Learning in Health Outcomes Research and Some Statistical Cautions
William H. Crown
VALUE IN HEALTH (2015)
Machine learning applications in cancer prognosis and prediction
Konstantina Kourou et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study
Stefan Kloeppel et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Long-Term Mortality in a Cohort of Home-Dwelling Elderly with Mild Alzheimer's Disease and Lewy Body Dementia
Ragnhild Oesterhus et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2014)
Mild Cognitive Impairment and Mild Dementia: A Clinical Perspective
David S. Knopman et al.
MAYO CLINIC PROCEEDINGS (2014)
Characterization of Atrophic Changes in the Cerebral Cortex Using Fractal Dimensional Analysis
Richard D. King et al.
BRAIN IMAGING AND BEHAVIOR (2009)
CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies
A. J. Mitchell
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
The uniform data set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer disease centers
John C. Morris et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)